Invest in the Future of Microbiome Science
Arkaïya is at the forefront of a paradigm shift in microbiome diagnostics and probiotics. Leveraging proprietary technologies and a pioneering focus on archaea, we are disrupting markets with precision solutions for gut health and beyond.
Key Highlights
- First-Mover Advantage: Launching the world’s first M. smithii PCR test.
- Patented Technologies: Strategic IP portfolio for archaea-based probiotics and diagnostics.
- Scalable Impact: Addressing unmet needs across human, veterinary, and aquaculture health.
- Unique Product Strengths: Heat stability, compatibility with antibiotic treatments, and gut pH regulation.
On the Horizon
Our innovative pipeline includes groundbreaking advancements in both diagnostics and probiotics, positioning us for transformative market impact in the years ahead.
Join us in revolutionizing gut health and advancing the science of the microbiome!